Development of new treatments for complex chronic comorbidities

P. J. Barnes (London, United Kingdom)

Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Number: 18
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. J. Barnes (London, United Kingdom). Development of new treatments for complex chronic comorbidities. Research Seminar 2006 - Complexity of patients with multiple chronic diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Carbonyl stress and enhanced macrophage function
Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD
Year: 2005

Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008



Osteoporosis and inflammation
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Implications for disease and therapy
Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD
Year: 2005

Interstitial lung disease induced by exogenous agents: factors governing susceptibility
Source: Eur Respir J 2001; 18: 30S-42S
Year: 2001



COPD: inflammatory mechanisms and systemic consequences
Source: Eur Respir Mon 2013; 59: 13-27
Year: 2013


The role of inflammation in cachexia
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



The role of inflammation in COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Resolution of inflammation in airway diseases
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005

Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Source: Eur Respir J 2003 Oct 01;22(4):672-688
Year: 2003



Induction of TGF-β and reactive oxygen species expression in bronchial epithelial cell by urban ambient air particulate matter
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006


Exploitation of anti-inflammatory mechanisms for the treatment of severe asthma
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005

Dual effect of neutrophils on secretory component production by human bronchial epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006


The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD
Source: Annual Congress 2005 - Protease-antiprotease revisited
Year: 2005

Endogenous lipid mediators in the resolution of airway inflammation
Source: Eur Respir J 2007; 30: 980-992
Year: 2007



Endothelial dysfunction, biology and oxidative stress in PAH
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005

Role of anti-proliferative therapy in PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008


Desferrioxamine attenuates minor lung injury following surgical acute liver failure
Source: Eur Respir J 2009; 33: 1429-1436
Year: 2009



Biomarkers of lipid peroxidation, airway inflammation and asthma
Source: Eur Respir J 2003; 21: 177-186
Year: 2003